We are live on ! Find out more
ROIV icon

Roivant Sciences

78 hedge funds and large institutions have $1.19B invested in Roivant Sciences in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 27 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

155% more call options, than puts

Call options by funds: $566K | Put options by funds: $222K

114% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 7

59% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 17

10% more funds holding

Funds holding: 7178 (+7)

1.23% more ownership

Funds ownership: 51.44%52.67% (+1.2%)

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

19% less capital invested

Capital invested by funds: $1.47B → $1.19B (-$274M)

Holders
78
Holders Change
+7
Holders Change %
+9.86%
% of All Funds
1.34%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
15
Increased
27
Reduced
17
Closed
7
Calls
$566K
Puts
$222K
Net Calls
+$344K
Net Calls Change
+$442K
Name Holding Trade Value Shares
Change
Change in
Stake
Tudor Investment Corp
26
Tudor Investment Corp
Connecticut
$1.14M +$1.14M +293,459 +484%
Northern Trust
27
Northern Trust
Illinois
$953K +$115K +29,805 +11%
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$910K +$14.8K +3,814 +1%
UBS AM
29
UBS AM
Illinois
$878K +$139K +35,783 +15%
EWM
30
Edge Wealth Management
New York
$871K +$1.04M +268,032 New
California State Teachers Retirement System (CalSTRS)
31
California State Teachers Retirement System (CalSTRS)
California
$769K +$6.59K +1,703 +0.7%
Renaissance Technologies
32
Renaissance Technologies
New York
$732K +$554K +143,100 +170%
CS
33
Credit Suisse
Switzerland
$685K -$160K -41,255 -16%
Goldman Sachs
34
Goldman Sachs
New York
$639K -$10.4K -2,680 -1%
CC
35
Centiva Capital
New York
$501K -$1.35M -349,566 -69%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$478K +$457K +118,094 +391%
Marshall Wace
37
Marshall Wace
United Kingdom
$461K +$555K +143,413 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$384K +$17.4K +4,493 +4%
Legal & General Group
39
Legal & General Group
United Kingdom
$315K +$379K +97,917 New
Janus Henderson Group
40
Janus Henderson Group
United Kingdom
$300K +$98.6K +25,461 +38%
Teacher Retirement System of Texas
41
Teacher Retirement System of Texas
Texas
$275K +$163K +42,199 +97%
Millennium Management
42
Millennium Management
New York
$269K +$324K +83,688 New
PFO
43
Pathstone Family Office
New Jersey
$248K +$158K +40,715 +112%
ASRS
44
Arizona State Retirement System
Arizona
$242K +$801 +207 +0.3%
VEA
45
Virtus ETF Advisers
New York
$203K +$3.59K +927 +1%
Mitsubishi UFJ Asset Management
46
Mitsubishi UFJ Asset Management
Japan
$160K
PI
47
PEAK6 Investments
Illinois
$160K +$173K +44,787 +896%
Susquehanna International Group
48
Susquehanna International Group
Pennsylvania
$137K +$23.7K +6,118 +17%
Morgan Stanley
49
Morgan Stanley
New York
$132K +$58K +14,982 +57%
JP Morgan Chase
50
JP Morgan Chase
New York
$131K +$11.1K +2,866 +8%

ROIV Hedge Fund Activity: Q3 2022 in Review

78 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q3 2022, worth a combined $1.19B — down 19% from $1.47B a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new ROIV positions and 7 closed out — a net gain of 8 holders — while 27 added to existing stakes and 17 trimmed.

The largest buyer was Adage Capital Partners, adding an estimated $10.5M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $3.57M sold.

  • 78 institutional investors held Roivant Sciences (ROIV) as of Q3 2022, up from 71 in Q2 2022.
  • Funds reported $1.19B of Roivant Sciences stock for Q3 2022, down 19% quarter-over-quarter.
  • 15 funds opened new Roivant Sciences positions in Q3 2022 and 7 closed out, a net change of +8 holders.
  • The largest Roivant Sciences buyer in Q3 2022 was Adage Capital Partners, an estimated $10.5M added.
  • The largest Roivant Sciences seller in Q3 2022 was Point72 Asset Management, an estimated $3.57M sold.

Based on aggregated 13F filings for Q3 2022.